Ohman, E.M.

patient trial infarction ck-mb level troponin mortality elevation study syndrome outcome 30 days group heart treatment death angina artery angioplasty event model revascularisation abciximab eptifibatide month result analysis /iiia circulation country 6- month mortality pursuit value hospital ratio gusto investigator intervention disease table troponin t baseline cardiol creatinine clearance point angiography therapy follow-up effect creatinine state platelet occlusion category percutaneou 6 months placebo peak ck-mb level difference glycoprotein clearance restenosi gusto iv-acs troponin t level procedure figure characteristic <0.001 peak ck-mb ratios benefit 1- year mortality st-segment elevation st-segment necrosis creatine infarct surgery revascularization variation criteria